ASHLEY TOWE: Open Payments
NPI 1861816621 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,596 in 140 payments from 19 companies in 2025. Trend: 2023 $3,381 · 2024 $3,516 · 2025 $2,596
Food & beverage: $2,596
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $420 |
| Phathom Pharmaceuticals, Inc. | 17 | $335 |
| Lilly USA, LLC | 19 | $261 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $209 |
| Ardelyx, Inc. | 9 | $182 |
| Janssen Biotech, Inc. | 12 | $170 |
| Novo Nordisk Inc | 3 | $166 |
| Gilead Sciences, Inc. | 6 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $146 |
| Madrigal Pharmaceuticals | 6 | $140 |
Products named: VOQUEZNA, TREMFYA, OMVOH, XIFAXAN, IBSRELA, Wegovy, RINVOQ, REZDIFFRA.
Industry payments across KY — which companies pay providers there.
